BIOE Seminar: Xuan Xu

Friday, October 4, 2019
9:00 a.m.-10:00 a.m.
A. James Clark Hall, Room 2132
Emily Rosenthal
301 405 3936
erosent1@umd.edu

Dr. Xuan Xu
Field Application Scientist
RoosterBio, Inc.

Stem Cell Commercialization and Transitioning from Academia to Industry

Over 1000 global clinical trials have been initiated with hMSCs since 2011, with a record number 164 trials initiated in 2018 alone. The MSC paradigm is expanding to include gene modified cells, MSC-sourced exosomes or extracellular vesicles, and engineered tissues, organs and medical devices where MSCs are a raw material input during product manufacturing. RoosterBio, a regenerative medicine technology platform company, blasts open the most significant bottleneck in clinical trial initiation by radically simplifying the use of MSCs. RoosterBio’s high-volume, well-characterized adult hMSCs paired with highly engineered bioprocess media systems are built for rapid manufacturing scale-up, thus removing several years and millions of dollars from product development and clinical testing. This approach revolutionizes how regenerative medicine products are developed, clinically-translated, and commercialized.

About the Speaker

Xuan Xu is a a Field Application Scientist at RoosterBio, Inc. in Rockville, M.D. She earned her B.S. in Life Sciences from Fudan University, then her Ph.D. in Molecular Medicine from University of Texas Health Science Center at San Antonio. Before working at RoosterBio, Xu worked as a Research Fellow for the NCI and NIH, and was awarded the highly competitive Title 42 Research Fellowship from the NIH. 

 

Audience: Public 

remind we with google calendar

 

March 2024

SU MO TU WE TH FR SA
25 26 27 28 29 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31 1 2 3 4 5 6
Submit an Event